Last reviewed · How we verify
NCT05098535
Remembering Risk Using Visual Risk Display of MINS to Obtain Informed Consent to Undergo Elective Surgery
NA trial testing Visual Aid in Risk in 108 participants. Status unknown.
1 December 2021
Quick facts
| Lead sponsor | Queen's University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 108 |
| Start date | 28 October 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 July 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Visual Aid
- Scripted Risk Discussion
Conditions studied
- Risk — all drugs for Risk →
Sponsor
Queen's University
Who can join
45 and older, any sex, with Risk. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Disclosure of anticipated risks to individuals considering undergoing an elective operative procedure is an important aspect of informed consent process. Recent Canadian Guidelines have highlighted the importance of perioperative risk discussion within the context of preoperative assessment but there is little prior research into potential interventions to optimize the communication of risks. Myocaridal injury (MINS) is the most common complication and this study is focused on determining the effectiveness of current communication strategies in our presurgical consultations and to quantifying the impact of introducing a visual aid and scripted risk discussions has on patients ability to recall their individualized perioperative risk of myocardial injury.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05098535
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Visual Aid
Trials testing the same drug.
- NCT04247841 — Remembering Risk: Using Visual Risk Display of MINS to Obtain Informed Consent to Undergo Elective Surgery · NA · unknown
- NCT03592628 — Enhancing Postpartum Discharge Instructions · NA · completed
Other recruiting trials for Risk
Currently open trials in the same condition.
- NCT06715618 — The Use of the Functional Movement Screen™ in Preventing Injuries in Amateur Rugby Players · recruiting
- NCT05319158 — The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality. · NA · recruiting
Other Queen's University trials
Trials by the same sponsor.
- NCT07526103 — Developing a Colonoscopy Preparation Protocol for Patients With Diabetes · NA · not yet recruiting
- NCT07456670 — Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support · Phase 2 · not yet recruiting
- NCT06794723 — A Probiotic Based Intervention in Pregnancies Complicated by GDM · Phase 2 · not yet recruiting
- NCT07030426 — Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery · Phase 3 · not yet recruiting
- NCT07036653 — Bone Enhanced Ultrasound (BEUS) Data Library Development Project · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05098535 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen's University
- Last refreshed: 28 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05098535.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing